Xbira 250mg (Abiraterone)

Product Overview

Xbira 250mg is a prescription oral cancer medicine that contains Abiraterone Acetate, which is a powerful blocker of the biosynthesis of androgens. It’s primarily used for treatments of metastatic castration-resistant prostate cancer (mCRPC), where conventional hormone therapy does not work anymore.

Inhibiting the enzyme CYP17, Abiraterone reduces androgen levels not only in the testes but within the adrenal glands as well as the tumor tissue, which reduces testosterone levels and thus slows the expansion of prostate cancer cells.

Active Ingredient

• Abiraterone Acetate — 250 mg per tablet

Indications

Xbira 250mg is indicated for:

• Treatment for metastatic castration-resistant prostate cancer (mCRPC) in combination with prednisone.
• It is administered to those who previously had androgen deprivation therapy.
• It is a possibility to prescribe it for patients who’ve had chemotherapy before or who have been treated but do not require additional treatment to reduce the hormone.

Mechanism of Action

Abiraterone acetate acts as a selective, irreversible blocker of CYP17A1, which is the enzyme that is essential for androgen biosynthesis. By blocking CYP17A1, abiraterone:

• The drug blocks the generation of testosterone (testosterone as well as dihydrotestosterone) through the testes, adrenal glands, and prostate tumor tissues.
• The systemic reduction of levels of androgen. This reduces the stimulation of prostate cancer cell growth.
• The hormone suppression slows down the growth of tumors and accelerates progression in hormone-sensitive and resistant prostate cancer.

Dosage and Administration

• The most common dose for Xbira can be 1,000 mg (four 250 mg tablets) consumed orally every day with an empty stomach, at least 1 hour prior to or 2 hours after eating.
• It must be taken together with the low dose of prednisone (5 mg once each day) to manage side effects resulting from mineralocorticoid overdose.
• The treatment should be continued until progresses or toxicity becomes unacceptable.
• Modifications to dosages may be necessary for patients who experience adverse reactions or comorbidities specific to the patient.

Precautions and Warnings

• Mineralocorticoid excess: Abiraterone causes hypertension, hypokalemia, and the retention of fluids due to an increase in mineralocorticoid levels. The use of prednisone in combination with other treatments can help reduce these side effects.
• Monitor blood pressure, serum potassium, and liver function regularly.
• Take care when treating patients with a history of heart illness or liver disease.
• Do not recommend during pregnancy or for women who have the potential to have children.
• Hepatotoxicity may be a cause; test for liver function must be performed before beginning treatment, and then every few weeks throughout the course of therapy.
• Patients must be closely monitored for any signs of adrenal deficiency after the prednisone dose is stopped.

Side Effects

Common side effects include:

• Fatigue
• Joint swelling or discomfort
• Hot flashes
• Hypertension
• Hypokalemia (low potassium levels)
• Edema (swelling)
• Nausea
• Diarrhea

Serious but less common adverse events:

• Hepatotoxicity (elevated liver enzymes)
• Cardiac events (e.g., arrhythmias)
• Adrenal insufficiency
• Allergic reactions

Use in Special Populations

• Pregnancy: Contraindicated; abiraterone is teratogenic.
• Lactation: It is not known if it’s excreted in human milk. Nursing should stop.
• Hepatic Impairment: Take care when using this method in the case of moderate to mild impairment. It is not advised in cases of severe impairment.
• Elderly: A dose adjustment is not usually necessary; close observation is recommended.

Storage Instructions

• Maintain a temperature of 30°C (86°F) in an air-tight place.
• Beware of direct sunlight.
• Be sure to keep away from children.
• Don’t use past when the date of expiration is.

Patient Counseling Information

• It is recommended to take Xbira exactly as it is prescribed with a full stomach.
• Don’t eat for a minimum of 1 hour prior to and for 2 hours following the dosage.
• Prednisone should be taken as directed to minimize the risk of adverse reactions.
• Inform the doctor of any symptoms that are unusual, including chest discomfort, shortness of breath, or jaundice, as soon as you notice them.
• Make regular appointments to follow up on the monitoring of electrolytes, blood pressure, and the liver’s functioning.
• Do not drink grapefruit juice or grapefruit when you’re taking medication, since they could increase levels of abiraterone.

Conclusion

Xbira 250mg (Abiraterone Acetate) offers an effective hormone treatment for men suffering from metastatic cancer of the prostate. Because it targets androgen production at various sites, it reduces progress of the disease and increases patient results. When properly managed by medical professionals and compliance with doses, Xbira can be an essential component of prostate cancer treatment.